Submitted by Anonymous (not verified) on 13 October 2026 - 16:03
Human medicines European public assessment report (EPAR): Cometriq, cabozantinib, Date of authorisation: 21/03/2014, Revision: 34, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cometriq, cabozantinib, Date of authorisation: 21/03/2014, Revision: 34, Status: Authorised